Financhill
Buy
56

EMN Quote, Financials, Valuation and Earnings

Last price:
$63.24
Seasonality move :
3.45%
Day range:
$62.42 - $62.99
52-week range:
$56.11 - $103.82
Dividend yield:
5.3%
P/E ratio:
10.48x
P/S ratio:
0.81x
P/B ratio:
1.24x
Volume:
403.9K
Avg. volume:
1.7M
1-year change:
-31.35%
Market cap:
$7.2B
Revenue:
$9.4B
EPS (TTM):
$6.00

EMN Analysts' Consensus Rating

The 14 analysts providing 12-month price projections for Eastman Chemical Co. shares anticipate an average target of $73.35, ranging from a low estimate of $60.00 to a high estimate of $100.00. This average target implies a growth of 16.69% compared to the current stock price of $62.86.

Consensus Price Target

$73.35

Highest Price Target

$100.00

Lowest Price Target

$60.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 10 9 8

Hold 5 5 6

Sell 0 0 0
Consensus Buy Buy Buy

EMN Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 26

Travere Therapeutics, Inc. [TVTX] is down 0.62% over the past day.

Buy
64
ZCSH alert for Dec 26

Grayscale Zcash Trust (ZEC) [ZCSH] is down 2.27% over the past day.

Buy
66
ASTS alert for Dec 26

AST Spacemobile, Inc. [ASTS] is down 7.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock